IN2013MU03583A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03583A
IN2013MU03583A IN3583MU2013A IN2013MU03583A IN 2013MU03583 A IN2013MU03583 A IN 2013MU03583A IN 3583MU2013 A IN3583MU2013 A IN 3583MU2013A IN 2013MU03583 A IN2013MU03583 A IN 2013MU03583A
Authority
IN
India
Prior art keywords
praziquantel
relates
pharmaceutically acceptable
acceptable excipients
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Geena Malhotra
Preeti Raut
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN3583MU2013 priority Critical patent/IN2013MU03583A/en
Priority to PCT/GB2014/053366 priority patent/WO2015071668A1/en
Priority to ZA2014/08333A priority patent/ZA201408333B/en
Publication of IN2013MU03583A publication Critical patent/IN2013MU03583A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3583MU2013 2013-11-14 2014-11-13 IN2013MU03583A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN3583MU2013 IN2013MU03583A (pt) 2013-11-14 2014-11-13
PCT/GB2014/053366 WO2015071668A1 (en) 2013-11-14 2014-11-13 Pharmaceutical compositions
ZA2014/08333A ZA201408333B (en) 2013-11-14 2014-11-13 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3583MU2013 IN2013MU03583A (pt) 2013-11-14 2014-11-13

Publications (1)

Publication Number Publication Date
IN2013MU03583A true IN2013MU03583A (pt) 2015-07-31

Family

ID=51947385

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3583MU2013 IN2013MU03583A (pt) 2013-11-14 2014-11-13

Country Status (3)

Country Link
IN (1) IN2013MU03583A (pt)
WO (1) WO2015071668A1 (pt)
ZA (1) ZA201408333B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017003251A (es) 2014-09-12 2017-12-20 Antibiotx Aps Uso antibacteriano de salicilanilidas halogenadas.
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
CN106420782B (zh) * 2016-11-24 2019-01-18 成都乾坤动物药业股份有限公司 一种阿维菌素分散片及其制备方法
BR112019011502A2 (pt) * 2016-12-09 2019-11-05 Bayer Animal Health Gmbh preparação farmacêutica e método para sua fabricação
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
RU2722272C1 (ru) * 2019-04-30 2020-05-28 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Средство для лечения и профилактики нематодозов и цестодозов у мелких домашних животных
US20220047506A1 (en) * 2020-08-12 2022-02-17 Villya LLC Praziquantel Formulations
EP4362945A1 (en) * 2021-07-01 2024-05-08 The University Of Western Australia Fish feed additives
CN115869275A (zh) * 2022-12-27 2023-03-31 佛山市南海东方澳龙制药有限公司 一种动物用驱虫片及其制备方法
CN115844843A (zh) * 2022-12-27 2023-03-28 佛山市南海东方澳龙制药有限公司 多单元分散的驱虫片及其制备方法
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics
CN117771188A (zh) * 2023-12-25 2024-03-29 中原食品实验室 一种含阿苯达唑与伊维菌素的预混剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010063387A1 (de) * 2008-12-05 2010-06-10 Bayer Animal Health Gmbh Extrudate mit nadelförmigen wirkstoffen
HU231017B1 (hu) * 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk

Also Published As

Publication number Publication date
ZA201408333B (en) 2015-12-23
WO2015071668A1 (en) 2015-05-21

Similar Documents

Publication Publication Date Title
IN2013MU03583A (pt)
PH12015501648A1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12014501991B1 (en) Phenicol antibacterials
MX2015010829A (es) Compuestos terapeuticos y sus usos.
IN2014MN02236A (pt)
IN2013MU00711A (pt)
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
PH12015502564A1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
IN2013MU03428A (pt)
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
UA81932U (ru) Комбинированный препарат "ротрин-дента" в виде геля для лечения воспалительных заболеваний слизистой оболочки полости рта